Keyphrases
Caenorhabditis Elegans
100%
Neurodegeneration
100%
6-hydroxydopamine (6-OHDA)
100%
Dopaminergic Neurons
100%
Tetraspanin
100%
Parkinson's Disease
75%
DAT1
75%
Paralysis
50%
Dopaminergic Pathway
50%
Larval Stages
50%
Alzheimer's Disease
25%
Null mutant
25%
Gain-of-function mutation
25%
Membrane Protein
25%
Genetic Approach
25%
Negatively Regulate
25%
Worm
25%
Increased Incidence
25%
Neurotoxin
25%
Dopamine
25%
Lethality
25%
Neurodegenerative Diseases
25%
Genetic Risk
25%
Liquid Medium
25%
Forward Genetics
25%
Environmental Risk Factors
25%
Substantia Nigra
25%
Dopaminergic Neurodegeneration
25%
Hereditary Conditions
25%
Behavioral Phenotype
25%
Hermaphrodite
25%
Tetraspanin Family
25%
Pesticide Exposure
25%
Rural Living
25%
Dopamine Receptor
25%
Dopaminergic Signaling
25%
Dopamine Reuptake
25%
Medicine and Dentistry
Neurodegeneration
100%
Tetraspanin
100%
Dopaminergic Neuron
100%
Caenorhabditis Elegans
100%
Parkinson's Disease
75%
Paralysis
50%
Larval Stage
50%
Disease
25%
Alzheimer's Disease
25%
Degenerative Disease
25%
Oxidopamine
25%
Neurotoxin
25%
Lethality
25%
Substantia nigra
25%
Dopamine Receptor D2
25%
Neuroscience
Neurodegeneration
100%
Dopaminergic Neuron
100%
Tetraspanin
100%
Caenorhabditis Elegans
100%
Parkinson's Disease
75%
Dopaminergic
50%
Behavior (Neuroscience)
25%
Alzheimer's Disease
25%
Neurodegenerative Disorder
25%
Oxidopamine
25%
Transmembrane Protein
25%
Neurotoxin
25%
Substantia nigra
25%
Dopamine Receptor D2
25%
Reuptake
25%
Pharmacology, Toxicology and Pharmaceutical Science
Nerve Degeneration
100%
Caenorhabditis Elegans
100%
Dopamine Receptor Stimulating Agent
100%
Tetraspanin
100%
Parkinson's Disease
50%
Paralysis
33%
Disease
16%
Neurotoxin
16%
Degenerative Disease
16%
Alzheimer's Disease
16%
Lethality
16%
Oxidopamine
16%
Dopamine Receptor D2
16%
Biochemistry, Genetics and Molecular Biology
Caenorhabditis Elegans
100%
Dopaminergic
100%
Tetraspanin
100%
Genetics
50%
Larval Stage
33%
Transmembrane Protein
16%
Forward Genetics
16%
Genetic Approach
16%
Neurotoxin
16%
Reuptake
16%
Dopamine Receptor D2
16%